$1.49
7.19% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US13173L1070
Symbol
CBUS

Calyxt, Inc. Stock price

$1.49
-0.83 35.71% 1M
-2.60 63.60% 6M
-1.30 46.58% YTD
-8.55 85.19% 1Y
-264.02 99.44% 5Y
-561.02 99.74% 10Y
-561.02 99.74% 20Y
Nasdaq, Closing price Fri, Jun 13 2025
-0.12 7.19%
ISIN
US13173L1070
Symbol
CBUS
Sector
Industry

Key metrics

Market capitalization $80.16m
Enterprise Value $57.20m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 12.04
P/S ratio (TTM) P/S ratio 16.88
P/B ratio (TTM) P/B ratio 0.74
Revenue growth (TTM) Revenue growth 103.86%
Revenue (TTM) Revenue $4.75m
EBIT (operating result TTM) EBIT $-79.13m
Free Cash Flow (TTM) Free Cash Flow $-57.26m
Cash position $23.59m
EPS (TTM) EPS $-7.84
P/S forward 14.57
EV/Sales forward 10.40
Short interest 7.30%
Show more

Is Calyxt, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Calyxt, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Calyxt, Inc. forecast:

3x Buy
75%
1x Hold
25%

Analyst Opinions

4 Analysts have issued a Calyxt, Inc. forecast:

Buy
75%
Hold
25%

Financial data from Calyxt, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
4.75 4.75
104% 104%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 34 34
0% 0%
709%
- Research and Development Expense 50 50
4% 4%
1,057%
-72 -72
78% 78%
-1,525%
- Depreciation and Amortization 6.70 6.70
12% 12%
141%
EBIT (Operating Income) EBIT -79 -79
76% 76%
-1,666%
Net Profit -275 -275
4% 4%
-5,786%

In millions USD.

Don't miss a Thing! We will send you all news about Calyxt, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Calyxt, Inc. Stock News

Neutral
GlobeNewsWire
one day ago
Researchers at the John Innes Centre (JIC) have discovered a genetic mutation with the potential to enhance nutrient uptake and reduce the need for artificial fertilizers Cibus and JIC have agreed on a collaboration with the potential to introduce the trait into several commercial crops Cibus previously announced the successful editing of Canola plants with this mutation and looks forward to fu...
Neutral
GlobeNewsWire
4 days ago
SAN DIEGO, June 09, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the “Company” or “Cibus”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced the closing of its previously announced public offering of 15,714,285 shares of its Class A Common Stock, at a purch...
Neutral
GlobeNewsWire
8 days ago
This action follows the USDA's recent designation of Cibus' disease resistance traits in Canola as not regulated, continuing Cibus' product development momentum in the globally important Canola crop This action follows the USDA's recent designation of Cibus' disease resistance traits in Canola as not regulated, continuing Cibus' product development momentum in the globally important Canola crop
More Calyxt, Inc. News

Company Profile

Calyxt, Inc. is technology company, which engages in delivering plant-based solutions. Its products include high oleic soybean oil, high fiber wheat, high oleic soybean meal, and low lignin alfalfa. The company was founded by Daniel F. Voytas and André Choulika on January 8, 2010 and is headquartered in Roseville, MN.

Head office United States
CEO Peter Beetham
Employees 158
Founded 2001
Website www.cibus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today